+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "ADX-71149"

From
  • 2 Results (Page 1 of 1)
Loading Indicator

The ADX-71149 market is a subset of the Central Nervous System (CNS) Drugs market. It is composed of drugs used to treat neurological disorders such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis. These drugs are designed to improve cognitive function, reduce inflammation, and improve motor control. ADX-71149 is a drug that is being developed to treat Alzheimer's disease. It is a small molecule inhibitor of the enzyme acetylcholinesterase, which is responsible for breaking down the neurotransmitter acetylcholine. The ADX-71149 market is highly competitive, with many companies vying for a share of the market. Some of the major players in the market include AbbVie, AstraZeneca, Biogen, Eli Lilly, Merck, Novartis, Pfizer, and Roche. These companies are investing heavily in research and development to develop new drugs and treatments for neurological disorders. Show Less Read more